Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Stoke Therapeutics (STOK) Other Gross PP&E Adjustments (2021 - 2025)

Stoke Therapeutics has reported Other Gross PP&E Adjustments over the past 5 years, most recently at $9.2 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 26.31% year-over-year to $9.2 million; the TTM value through Dec 2025 reached $9.2 million, up 26.31%, while the annual FY2025 figure was $9.2 million, 26.31% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $9.2 million at Stoke Therapeutics, up from -$5.4 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $9.2 million in Q4 2025 and troughed at -$7.8 million in Q1 2024.
  • A 5-year average of -$2.2 million and a median of -$5.2 million in 2023 define the central range for Other Gross PP&E Adjustments.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 101.8% in 2022 and later crashed 82.83% in 2024.
  • Year by year, Other Gross PP&E Adjustments stood at $2.8 million in 2021, then surged by 101.8% to $5.6 million in 2022, then skyrocketed by 38.17% to $7.7 million in 2023, then dropped by 5.67% to $7.3 million in 2024, then grew by 26.31% to $9.2 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for STOK at $9.2 million in Q4 2025, -$5.4 million in Q3 2025, and -$4.3 million in Q2 2025.